CO14. A pivotal study evaluating efficacy and safety of the hedgehog pathway inhibitor (HPI) vismodegib (GDC-0449) in patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC)
2014 ◽
Vol 5
(4)
◽
2012 ◽
Vol 66
(4)
◽
pp. AB149
2014 ◽
Vol 71
(5)
◽
pp. 1005-1008
◽
2020 ◽
Vol 258
(10)
◽
pp. 2335-2337
◽
2017 ◽
Vol 32
(3)
◽
pp. 372-381
◽
2017 ◽
Vol 27
(4)
◽
pp. 386-392
◽